Effects of DOAC-Stop on clot waveform analysis of plasma spiked with antithrombin-dependent and antithrombin-independent anticoagulants

Yuko Ozaki; Masatoshi Wakui; Shusaku Oka; Yuta Fujimori; Yoshino Kondo; Shoko Nakamura; Emiri Osada; Terumichi Nakagawa; Hisako Katagiri; Hiromichi Matsushita

doi:10.1111/ijlh.14120

Effects of DOAC-Stop on clot waveform analysis of plasma spiked with antithrombin-dependent and antithrombin-independent anticoagulants

Yuko Ozaki
, Masatoshi Wakui
, Shusaku Oka
, Yuta Fujimori
, Yoshino Kondo
, Shoko Nakamura
, Emiri Osada
, Terumichi Nakagawa
, Hisako Katagiri
, Hiromichi Matsushita

臨床検査医学

研究成果: Letter › 査読

2 被引用数 (Scopus)

本文言語	English
ページ（範囲）	979-983
ページ数	5
ジャーナル	International Journal of Laboratory Hematology
巻	45
号	6
DOI	https://doi.org/10.1111/ijlh.14120
出版ステータス	Published - 2023 12月

ASJC Scopus subject areas

血液学
臨床生化学
生化学、医学

文献へのアクセス

10.1111/ijlh.14120

他のファイルとリンク

引用スタイル

Ozaki, Y, Wakui, M, Oka, S, Fujimori, Y, Kondo, Y, Nakamura, S, Osada, E, Nakagawa, T, Katagiri, H & Matsushita, H 2023, 'Effects of DOAC-Stop on clot waveform analysis of plasma spiked with antithrombin-dependent and antithrombin-independent anticoagulants', International Journal of Laboratory Hematology, vol. 45, no. 6, pp. 979-983. https://doi.org/10.1111/ijlh.14120

@article{7c36e6fa2a344c7795c3c87457c88295,

title = "Effects of DOAC-Stop on clot waveform analysis of plasma spiked with antithrombin-dependent and antithrombin-independent anticoagulants",

author = "Yuko Ozaki and Masatoshi Wakui and Shusaku Oka and Yuta Fujimori and Yoshino Kondo and Shoko Nakamura and Emiri Osada and Terumichi Nakagawa and Hisako Katagiri and Hiromichi Matsushita",

note = "Funding Information: The BMS/Pfizer Japan Thrombosis Investigator Initiated Research Program (JRISTA), which supported this work, is administered by the companies, Bristol‐Myers Squibb and Pfizer. Funding Information: This work was supported by JSPS KAKENHI Grant Number JP21H04267, which was funded by Japan Society for the Promotion of Science (JSPS), and by the BMS/Pfizer Japan Thrombosis Investigator Initiated Research Program (JRISTA). ",

year = "2023",

month = dec,

doi = "10.1111/ijlh.14120",

language = "English",

volume = "45",

pages = "979--983",

journal = "International Journal of Laboratory Hematology",

issn = "1751-5521",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Effects of DOAC-Stop on clot waveform analysis of plasma spiked with antithrombin-dependent and antithrombin-independent anticoagulants

AU - Ozaki, Yuko

AU - Wakui, Masatoshi

AU - Oka, Shusaku

AU - Fujimori, Yuta

AU - Kondo, Yoshino

AU - Nakamura, Shoko

AU - Osada, Emiri

AU - Nakagawa, Terumichi

AU - Katagiri, Hisako

AU - Matsushita, Hiromichi

N1 - Funding Information: The BMS/Pfizer Japan Thrombosis Investigator Initiated Research Program (JRISTA), which supported this work, is administered by the companies, Bristol‐Myers Squibb and Pfizer. Funding Information: This work was supported by JSPS KAKENHI Grant Number JP21H04267, which was funded by Japan Society for the Promotion of Science (JSPS), and by the BMS/Pfizer Japan Thrombosis Investigator Initiated Research Program (JRISTA).

PY - 2023/12

Y1 - 2023/12

UR - https://www.scopus.com/pages/publications/85162684202

UR - https://www.scopus.com/pages/publications/85162684202#tab=citedBy

U2 - 10.1111/ijlh.14120

DO - 10.1111/ijlh.14120

M3 - Letter

C2 - 37344981

AN - SCOPUS:85162684202

SN - 1751-5521

VL - 45

SP - 979

EP - 983

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

IS - 6

ER -